OTC Markets OTCPK - Delayed Quote USD
Genmab A/S (GNMSF)
198.11
0.00
(0.00%)
As of April 22 at 4:00:00 PM EDT. Market Open.
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
20.5
Environmental Risk Score
0.7
Social Risk Score
14.6
Governance Risk Score
5.1
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
JNJ Johnson & Johnson | 20 | 1 | 13 | 6 |
HALO Halozyme Therapeutics, Inc. | 20 | -- | -- | -- |
GNMSF Genmab A/S | 20 | 1 | 15 | 5 |
MRK Merck & Company, Inc. | 20 | 3 | 12 | 6 |
SARTF SARTORIUS AG | 20 | 1 | 11 | 8 |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 4/2025
GNMSF
Category Average
1 Low Controversy Level
None 4 Severe
1.0 GNMSF
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | No |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
IVBXF Innovent Biologics, Inc.
5.98
0.00%
PHVS Pharvaris N.V.
14.70
-2.58%
CGEM Cullinan Therapeutics, Inc.
8.49
+1.37%
UPB Upstream Bio, Inc.
10.01
-1.38%
LENZ LENZ Therapeutics, Inc.
26.74
+3.68%
STOK Stoke Therapeutics, Inc.
9.42
+2.11%
1801.HK INNOVENT BIO
51.450
-1.91%
IMCR Immunocore Holdings plc
29.96
+1.49%
ORIC ORIC Pharmaceuticals, Inc.
5.29
+1.39%
VOR Vor Biopharma Inc.
0.7823
+11.44%